Carole Ho
2017
In 2017, Carole Ho earned a total compensation of $1.4M as Chief Medical Officer at Denali Therapeutics, a 33% increase compared to previous year.
Compensation breakdown
| Bonus | $203,425 |
|---|---|
| Option Awards | $746,025 |
| Salary | $406,850 |
| Other | $11,697 |
| Total | $1,367,997 |
Ho received $746K in option awards, accounting for 55% of the total pay in 2017.
Ho also received $203.4K in bonus, $406.9K in salary and $11.7K in other compensation.
Rankings
In 2017, Carole Ho's compensation ranked 7,453rd out of 14,666 executives tracked by ExecPay. In other words, Ho earned more than 49.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,453 out of 14,666 | 49th |
Division Manufacturing | 2,779 out of 5,772 | 52nd |
Major group Chemicals And Allied Products | 901 out of 2,075 | 57th |
Industry group Drugs | 704 out of 1,731 | 59th |
Industry Biological Products, Except Diagnostic Substances | 134 out of 313 | 57th |
Source: SEC filing on April 26, 2018.
Ho's colleagues
We found three more compensation records of executives who worked with Carole Ho at Denali Therapeutics in 2017.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019